BACKGROUND: Public insurance for testing supplies for self-monitoring of blood glucose is highly variable across Canada. We sought to determine if insured patients were more likely than uninsured patients to use self-monitoring and whether they had better glycemic control. METHODS: We used baseline survey and laboratory data from patients enrolled in a randomized controlled trial examining the effect of paying for testing supplies on glycemic control. We recruited patients through community pharmacies in Alberta and Saskatchewan from Nov. 2001 to June 2003. To avoid concerns regarding differences in provincial coverage of self-monitoring and medications, we report the analysis of Alberta patients only. RESULTS: Among our sample of 405 patients, 41% had private or public insurance coverage for self-monitoring testing supplies. Patients with insurance had significantly lower hemoglobin A(1c) concentrations than those without insurance coverage (7.1% v. 7.4%, p = 0.03). Patients with insurance were younger, had a higher income, were less likely to have a high school education and were less likely to be married or living with a partner. In multivariate analyses that controlled for these and other potential confounders, lack of insurance coverage for self-monitoring testing supplies was still significantly associated with higher hemoglobin A(1c) concentrations (adjusted difference 0.5%, p = 0.006). INTERPRETATION: Patients without insurance for self-monitoring test strips had poorer glycemic control.
RCT Entities:
BACKGROUND: Public insurance for testing supplies for self-monitoring of blood glucose is highly variable across Canada. We sought to determine if insured patients were more likely than uninsured patients to use self-monitoring and whether they had better glycemic control. METHODS: We used baseline survey and laboratory data from patients enrolled in a randomized controlled trial examining the effect of paying for testing supplies on glycemic control. We recruited patients through community pharmacies in Alberta and Saskatchewan from Nov. 2001 to June 2003. To avoid concerns regarding differences in provincial coverage of self-monitoring and medications, we report the analysis of Alberta patients only. RESULTS: Among our sample of 405 patients, 41% had private or public insurance coverage for self-monitoring testing supplies. Patients with insurance had significantly lower hemoglobin A(1c) concentrations than those without insurance coverage (7.1% v. 7.4%, p = 0.03). Patients with insurance were younger, had a higher income, were less likely to have a high school education and were less likely to be married or living with a partner. In multivariate analyses that controlled for these and other potential confounders, lack of insurance coverage for self-monitoring testing supplies was still significantly associated with higher hemoglobin A(1c) concentrations (adjusted difference 0.5%, p = 0.006). INTERPRETATION:Patients without insurance for self-monitoring test strips had poorer glycemic control.
Authors: David E Goldstein; Randie R Little; Rodney A Lorenz; John I Malone; David M Nathan; Charles M Peterson Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: M Franciosi; F Pellegrini; G De Berardis; M Belfiglio; D Cavaliere; B Di Nardo; S Greenfield; S H Kaplan; M Sacco; G Tognoni; M Valentini; A Nicolucci Journal: Diabetes Care Date: 2001-11 Impact factor: 19.112
Authors: Keith G Dawson; Daniel Gomes; Hertzel Gerstein; James F Blanchard; Kristijan H Kahler Journal: Diabetes Care Date: 2002-08 Impact factor: 19.112
Authors: Kira Evans; Josef Coresh; Lori D Bash; Tiffany Gary-Webb; Anna Köttgen; Kathryn Carson; L Ebony Boulware Journal: Nephrol Dial Transplant Date: 2010-08-05 Impact factor: 5.992
Authors: Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; James Chan; Michele M Spence; Joe V Selby; Susan L Ettner Journal: Am J Manag Care Date: 2007-07 Impact factor: 2.229
Authors: Suan Ee Ong; Joel Jun Kai Koh; Sue-Anne Ee Shiow Toh; Kee Seng Chia; Dina Balabanova; Martin McKee; Pablo Perel; Helena Legido-Quigley Journal: PLoS One Date: 2018-03-29 Impact factor: 3.240
Authors: Alicia A Gonzalez-Zacarias; Ana Mavarez-Martinez; Carlos E Arias-Morales; Nicoleta Stoicea; Barbara Rogers Journal: Front Public Health Date: 2016-09-12